Strategies for cancer gene therapy using adenoviral vectors

被引：8

作者：

Descamps, V ^{[1
]}

Duffour, MT ^{[1
]}

Mathieu, MC ^{[1
]}

Fernandez, N ^{[1
]}

Cordier, L ^{[1
]}

Abina, MA ^{[1
]}

Kremer, E ^{[1
]}

Perricaudet, M ^{[1
]}

Haddada, H ^{[1
]}

机构：

[1] INST GUSTAVE ROUSSY,F-94805 VILLEJUIF,FRANCE

来源：

JOURNAL OF MOLECULAR MEDICINE-JMM | 1996年 / 74卷 / 04期

关键词：

adenoviral vector; gene therapy; cancer; immunotherapy;

D O I：

暂无

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Modification of tumor cells using gene transfer either to enhance host immunity or to act directly on tumor cells is being intensively studied in animal models. Remarkable results have yielded to approved clinical protocols in the treatment of cancer patients using this approach. Several methods of gene delivery have been developed. This article is particularly devoted to the interest of the use of adenoviral vectors in the different strategies of cancer gene therapy.

引用

收藏

页码：183 / 189

页数：7

相关论文

共 68 条

[1] EXPRESSION OF MURINE INTERLEUKIN-7 IN A MURINE GLIOMA CELL-LINE RESULTS IN REDUCED TUMORIGENICITY INVIVO [J].

AOKI, T ;

TASHIRO, K ;

MIYATAKE, S ;

KINASHI, T ;

NAKANO, T ;

ODA, Y ;

KIKUCHI, H ;

HONJO, T .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (09) :3850-3854

[2]

ASHER AL, 1991, J IMMUNOL, V146, P3227

[3] DEVELOPMENT OF ANTITUMOR IMMUNITY FOLLOWING THYMIDINE KINASE-MEDIATED KILLING OF EXPERIMENTAL BRAIN-TUMORS [J].

BARBA, D ;

HARDIN, J ;

SADELAIN, M ;

GAGE, FH .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (10) :4348-4352

[4] TUMOR SUPPRESSION AFTER TUMOR-CELL TARGETED TUMOR-NECROSIS-FACTOR-ALPHA GENE-TRANSFER [J].

BLANKENSTEIN, T ;

QIN, ZH ;

UBERLA, K ;

MULLER, W ;

ROSEN, H ;

VOLK, HD ;

DIAMANTSTEIN, T .

JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (05) :1047-1052

[5] INHIBITION OF MELANOMA GROWTH BY ADENOVIRAL-MEDIATED HSV THYMIDINE KINASE GENE-TRANSFER IN-VIVO [J].

BONNEKOH, B ;

GREENHALGH, DA ;

BUNDMAN, DS ;

ECKHARDT, JN ;

LONGLEY, MA ;

CHEN, SH ;

WOO, SLC ;

ROOP, DR .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1995, 104 (03) :313-317

[6] IMMUNOTHERAPY OF CANCER USING LOCAL-ADMINISTRATION OF LYMPHOID-CELLS TRANSFORMED BY IL-2 CDNA AND CONSTITUTIVELY PRODUCING IL-2 [J].

BUBENIK, J ;

SIMOVA, J ;

JANDLOVA, T .

IMMUNOLOGY LETTERS, 1990, 23 (04) :287-292

[7] STABLE EXPRESSION OF THE WILD-TYPE P53 GENE IN HUMAN LUNG-CANCER CELLS AFTER RETROVIRUS-MEDIATED GENE-TRANSFER [J].

CAI, DW ;

MUKHOPADHYAY, T ;

LIU, YJ ;

FUJIWARA, T ;

ROTH, JA .

HUMAN GENE THERAPY, 1993, 4 (05) :617-624

[8] COSTIMULATION OF ANTITUMOR IMMUNITY BY THE B7 COUNTERRECEPTOR FOR THE LYMPHOCYTE-T MOLECULES CD28 AND CTLA-4 [J].

CHEN, LP ;

ASHE, S ;

BRADY, WA ;

HELLSTROM, I ;

HELLSTROM, KE ;

LEDBETTER, JA ;

MCGOWAN, P ;

LINSLEY, PS .

CELL, 1992, 71 (07) :1093-1102

[9] GENE-THERAPY FOR BRAIN-TUMORS - REGRESSION OF EXPERIMENTAL GLIOMAS BY ADENOVIRUS-MEDIATED GENE-TRANSFER IN-VIVO [J].

CHEN, SH ;

SHINE, HD ;

GOODMAN, JC ;

GROSSMAN, RG ;

WOO, SLC .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (08) :3054-3057

[10] GRANULOCYTE COLONY-STIMULATING FACTOR GENE-TRANSFER SUPPRESSES TUMORIGENICITY OF A MURINE ADENOCARCINOMA INVIVO [J].

COLOMBO, MP ;

FERRARI, G ;

STOPPACCIARO, A ;

PARENZA, M ;

RODOLFO, M ;

MAVILIO, F ;

PARMIANI, G .

JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (04) :889-897

← 1 2 3 4 5 6 7 →